Daniel Rea

Publications

  1. 2016
  2. Published

    Cardiac safety of simultaneous anti-HER2 and anthracycline therapy

    Mariam Jafri & Daniel Rea, Feb 2016, In: Breast Cancer Management. 5, 1, p. 21-29

    Research output: Contribution to journalArticlepeer-review

  3. Published
  4. Published
  5. 2015
  6. Published

    Addressing overtreatment of screen detected DCIS; the LORIS trial

    Toon Brookes, Tracy Roberts, Sarah Pirrie, Lucinda Billingham & 2 others, Sarah Bowden & Daniel Rea, Nov 2015, In: European Journal of Cancer. 51, 16, p. 2296-2303 8 p.

    Research output: Contribution to journalArticlepeer-review

  7. Published

    Aromatase inhibitors versus tamoxifen in early breast cancer: Patient-level meta-analysis of the randomised trials

    Richard Gray & , 3 Oct 2015, In: The Lancet. 386, 10001, p. 1341-1352 12 p.

    Research output: Contribution to journalArticlepeer-review

  8. Published
  9. Published

    Predicting anthracycline benefit: TOP2A and CEP17 - Not only but also

    Daniel Rea, , & , 20 May 2015, In: Journal of Clinical Oncology. 33, 15, p. 1680-1687 8 p.

    Research output: Contribution to journalArticlepeer-review

  10. Published
  11. Published

    The LORIS Trial: Addressing Overtreatment of Ductal Carcinoma In Situ

    Daniel Rea, 1 Jan 2015, In: Clinical Oncology. 27, 1, p. 6-8

    Research output: Contribution to journalEditorialpeer-review

  12. 2014
  13. Published

    Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer

    Toon Brookes, Daniel Rea, , , , , & , 9 Dec 2014, In: British Journal of Cancer. 111, 12, p. 2242-2247 6 p.

    Research output: Contribution to journalArticlepeer-review

Previous 12 3 4 5 6 7 8 9 ...13 Next